Joint symposium with the ISHLT: End-stage PAH - how and what do we do in 2021?

27 October 2021

  • days
  • Hours
  • Minutes

Chair and moderators

Paul Corris, University of Newcastle, UK

Mardi Gomberg-Maitland, GW University Medicine and Health Sciences, USA

Walter Klepetko, Medical University of Vienna, Austria

Agenda

  • John Granton // When should a PH patient be considered for lung transplant?
  • Erika Rosenzweig // Atrial septum defect creation or mechanical support for end-stage PAH
  • Eugene Golts // Lung and Heart-lung Transplant in 2021 – how well do PAH patients do?
  • Ulrich Martin // Pluripotent stem cell-based approaches and the future of artificial lungs
  • Ryan Tedford // Timing and extent of ventricular reverse remodelling after lung transplant for PH

A deeper look

When should a PH patient be considered for lung transplant?

15:00-15:15 BST

Presenter: // John Granton, Toronto General Hospital, Canada

Awaiting further information 

 

Atrial septum defect creation or mechanical support for end-stage PAH

15:24-15:39 BST

Presenter: // Erika Berman-Rosenzweig, Columbia University Medical Center, USA

Awaiting further information

 

Lung and Heart-lung Transplant in 2021 – how well do PAH patients do? 

15:48-16:03 BST

Presenter: // Eugene Golts, University of California, USA

Awaiting further information

 

Pluripotent stem cell-based approaches and the future of artificial lungs

16:12-16:27 BST

Presenter: // Ulrich Martin, Hannover Medical School, Germany

Awaiting further information

 

Timing and extent of ventricular reverse remodelling after lung transplant for PH

16:36-16:51 BST

Presenter: // Ryan Tedford, Medical University of South Carolina (MUSC), USA

Awaiting further information

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg